Kailash Singh
Researcher at Department of Medical Cell Biology; Research Group Stellan Sandler
- E-mail:
- kailash.singh@mcb.uu.se
- Visiting address:
- BMC
Husargatan 3
751 23 Uppsala - Postal address:
- Box 571
751 23 UPPSALA
More information is available to staff who log in.
Publications
Selection of publications
- Diabetic complications and prospective immunotherapy (2023)
- Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes (2022)
- Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development (2022)
- Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells (2021)
- Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes (2019)
- Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide (2017)
- Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice (2015)
- Interleukin-35 administration counteracts established murine type 1 diabetes - possible involvement of regulatory T cells (2015)
Recent publications
- Investigating the effects of radiation, T cell depletion, and bone marrow transplantation on murine gut microbiota (2024)
- Diabetic complications and prospective immunotherapy (2023)
- Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes (2022)
- Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development (2022)
- Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells (2021)
All publications
Articles
- Investigating the effects of radiation, T cell depletion, and bone marrow transplantation on murine gut microbiota (2024)
- Diabetic complications and prospective immunotherapy (2023)
- Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes (2022)
- Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development (2022)
- Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells (2021)
- Significance of host heparanase in promoting tumor growth and metastasis (2020)
- The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors (2019)
- Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes (2019)
- Determination of Regulatory T Cell Subsets in Murine Thymus, Pancreatic Draining Lymph Node and Spleen Using Flow Cytometry (2019)
- Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes (2019)
- Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas (2018)
- Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis (2017)
- Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide (2017)
- Role of regulatory B cells in clinical and experimental type 1 diabetes (2017)
- Kinetics of innate immune and regulatory T cells responses in experimental diabetic nephropathy (2017)
- Kinetics of the innate immune cell responses in experimental Type 1 Diabetes (2017)
- The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control (2017)
- Kinetics of the Foxp3(+) cell response in kidney tissue of both autoimmune and non-autoimmune induced hyperglycemia in mice (2016)
- Heparan Sulfate Proteoglycans Are Important for Islet Amyloid Formation and Islet Amyloid Polypeptide-induced Apoptosis (2015)
- Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice (2015)
- Interleukin-35 administration counteracts established murine type 1 diabetes - possible involvement of regulatory T cells (2015)
- The Kinetics of Thymic-Derived and Peripherally Induced Regulatory T Cell Response in Early Development of Type 1 Diabetes in a Murine Experimental Model (2014)
- Functional Impairment of Regulatory T Cells in the Early Development of T1D in the MLDSTZ Murine Model (2013)
- Kinetics of regulatory T cells in early development of type 1 diabetes in MLDSTZ induced murine model (2012)
- Characterization of Cellular Immunology in LADA Patients
Books
